Tag:
Illumina
Latest Headlines
Latest Headlines
Pharma rides a wave of targeted M&A deals
The reasons behind the dealmaking aren't new: Established markets are slowing down as emerging markets speed up, sending companies shopping in the developing world.
Illumina to open app store for genomics, releases iPad app
Illumina has ripped a page from Apple's playbook and begun development of an app store for genomics software.
Life Technologies expands manufacturing in Scotland
Life Technologies is lining up its pieces to get more of the genetic sequencing market with a manufacturing plant expansion in Scotland.
Illumina results impress despite Roche drama
Even though it was distracted by a hostile takeover attempt by Roche ($RHHBY), Illumina ($ILMN), posted better-than-expected results this week for its first quarter.
Spurned by Illumina, Roche may be eyeing universities for gene-sequencing tech
Roche ($RHHBY) is bound and determined to boost its presence in the molecular diagnostics business. Days after giving up on its $6.7 billion hostile bid for Illumina ($ILMN), a newspaper is reporting the drugmaker may be turning to intellectual property at three universities in its push to acquire gene-sequencing technology.
Roche decides to fold up its tent when Illumina offer expires
Roche said it wouldn't extend its $51-per-share bid for Illumina.
Roche's bid for Illumina may be kaput
After an apparently unsuccessful attempt to stack Illumina's board in its favor, Roche appears to be heading toward ending its $51-per-share, $6.7 billion bid for the California company.
Roche says it won't extend Illumina offer past Friday deadline
Roche is drawing a line in the sand in its standoff with Illumina.
Roche jeers at Illumina's boasts as proxy fight escalates
Roche has extended its offer twice, but Illumina doesn't appear to be listening.
Latest Illumina rejection stings Roche
Illumina ($ILMN) is standing firm against Roche's ($RHHBY) ongoing attempts to take it over.
